Novel Metabolites Are Associated With Augmentation Index and Pulse Wave Velocity: Findings From the Bogalusa Heart Study

被引:21
|
作者
Li, Changwei [1 ,2 ]
He, Jiang [2 ,3 ]
Li, Shengxu [2 ]
Chen, Wei [2 ]
Bazzano, Lydia [2 ]
Sun, Xiao [2 ]
Shen, Luqi [1 ]
Liang, Lirong [4 ]
Shen, Ye [1 ]
Gu, Xiaoying [5 ]
Kelly, Tanika N. [2 ]
机构
[1] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA
[2] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[3] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70118 USA
[4] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Clin Epidemiol & Tobacco Dependence Treatment Res, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
关键词
arterial stiffness; blood pressure; hypertension; metabolomics; metabolite networks; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; DOPAMINE AGONISTS; PREDICTOR; MORTALITY; DISEASE; ACIDS; RISK; MEN;
D O I
10.1093/ajh/hpz046
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND Metabolomics study may help identify novel mechanisms underlying arterial stiffening. METHODS We performed untargeted metabolomics profiling among 1,239 participants of the Bogalusa Heart Study. After quality control, 1,202 metabolites were evaluated for associations with augmentation index (AI) and pulse wave velocity (PWV), using multivariate linear regression adjusting for age, sex, race, education, smoking, drinking, body weight, body height, physical activity, and estimated glomerular filtration rate. Heart rate, blood pressure and antihypertensive medication usage, lipids, and fasting glucose were sequentially adjusted in the sensitivity analyses for significant metabolites. Weighted correlation network analysis was applied to build metabolite networks. RESULTS Six novel metabolites were negatively associated with AI, of which, 3-methyl-2-oxobutyrate had the lowest P value and the largest effect size (beta = -6.67, P = 5.99 x 10(-6)). Heart rate contributed to a large proportion (25%-58%) of the association for each metabolite. Twenty-one novel metabolites were identified for PWV, of which, fructose (beta = 0.61, P = 6.18 x 10(-10)) was most significant, and histidine had the largest effect size (beta = -1.09, P = 2.51 x 10(-7)). Blood pressure played a major contribution (9%-54%) to the association for each metabolite. Furthermore, 16 metabolites were associated with arterial stiffness independent of traditional risk factors. Network analysis identified 2 modules associated with both AI and PWV (P < 8.00 x 10(-4)). One was composed of metabolites from the glycerolipids synthesis and recycling pathway, and the other was involved in valine, leucine, and isoleucine metabolism. One module related to sphingomyelin metabolism was associated with PWV only (P = 0.002). CONCLUSIONS This study has identified novel and important metabolites and metabolic networks associated with arterial stiffness.
引用
收藏
页码:547 / 556
页数:10
相关论文
共 50 条
  • [31] The Analysis of Arterial Stiffness in Heart Failure Patients: The Prognostic Role of Pulse Wave Velocity, Augmentation Index and Stiffness Index
    Anastasio, Fabio
    Testa, Marzia
    Ferreri, Cinzia
    Rossi, Arianna
    Ruocco, Gaetano
    Feola, Mauro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [32] PULSE WAVE VELOCITY AND ABNORMAL AUGMENTATION INDEX IN THE SHOWCASE OF VASCULAR SENESCENCE
    Fabregate-Fuente, M.
    Tello-Blasco, S.
    Fernandez-Fernandez, C.
    Martin-Fernandez, L.
    Barrio-Carreras, D.
    Fabregate-Fuente, R.
    Rodriguez-Guerrero, A.
    Gomez-Olmos, C.
    Ortiz-Barraza, E.
    Camacho-Aguirre, A.
    Saban-Ruiz, J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E158 - E158
  • [33] Aortic Pulse Wave Velocity, Reflection Site Distance, and Augmentation Index
    Nichols, Wilmer W.
    O'Rourke, Michael F.
    HYPERTENSION, 2009, 53 (01) : E9 - E9
  • [34] Aortic pulse wave velocity is increased in diabetic patients but augmentation index is not
    Zoungas, S.
    Cameron, J. D.
    Giannopoulos, D.
    Martin, C. A.
    Kerr, P. G.
    Teede, H. J.
    McGrath, B. P.
    HYPERTENSION, 2007, 49 (06) : 1480 - 1480
  • [35] Novel Serum Metabolites Associate With Diastolic Function: Evidence From the Bogalusa Heart Study
    Razavi, Alexander C.
    Fernandez, Camilo
    Mi, Xuenan
    He, Jiang
    Bazzano, Lydia
    Nierenberg, Jovia
    Li, Shengxu
    Kelly, Tanika N.
    CIRCULATION, 2019, 139
  • [36] Different haemodynamic determinants of aortic pulse wave velocity and central pulse pressure augmentation index: an invasive study
    Franchi, E.
    De Luca, G.
    Giuliani, L.
    Venegoni, L.
    Rondano, E.
    Dell'era, G.
    Iorio, S.
    Marino, P.
    EUROPEAN HEART JOURNAL, 2009, 30 : 250 - 250
  • [37] Measurement of pulse wave velocity, augmentation index, and central pulse pressure in atrial fibrillation: a proof of concept study
    Caluwe, Rogier
    De Vriese, An S.
    Van Vlem, Bruno
    Verbeke, Francis
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (08) : 627 - 632
  • [38] Ankle Brachial Index not Pulse Wave Velocity is Associated with the Severity of Coronary Heart Disease
    Zhang, Yan
    Li, Jianping
    Huo, Yong
    CIRCULATION, 2010, 122 (02) : E125 - E125
  • [39] Combined effect of pulse wave velocity and augmentation index on mortality in an elderly popullation: The PROTEGER study
    Protogerou, A.
    Safar, M.
    Papaioannou, T.
    Iaria, P.
    Safar, H.
    Ducimetiere, R.
    Blacher, J.
    JOURNAL OF HYPERTENSION, 2008, 26 : S445 - S446
  • [40] P1.05: Aortic Pulse Wave Velocity But Not Augmentation Index is Associated with Asymptomatic Carotid Atherosclerosis
    T. Kahan
    R. Böcskei
    M. Illyes
    A. Cziraki
    Artery Research, 2013, 7 (3-4) : 112 - 112